These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 26844644)

  • 21. Lactobionic acid coupled liposomes: an innovative strategy for targeting hepatocellular carcinoma.
    Bansal D; Yadav K; Pandey V; Ganeshpurkar A; Agnihotri A; Dubey N
    Drug Deliv; 2016; 23(1):140-6. PubMed ID: 24786484
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Poly(lactide-co-glycolide) microspheres for MRI-monitored delivery of sorafenib in a rabbit VX2 model.
    Chen J; White SB; Harris KR; Li W; Yap JW; Kim DH; Lewandowski RJ; Shea LD; Larson AC
    Biomaterials; 2015 Aug; 61():299-306. PubMed ID: 26022791
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metformin sensitizes sorafenib to inhibit postoperative recurrence and metastasis of hepatocellular carcinoma in orthotopic mouse models.
    You A; Cao M; Guo Z; Zuo B; Gao J; Zhou H; Li H; Cui Y; Fang F; Zhang W; Song T; Li Q; Zhu X; Yin H; Sun H; Zhang T
    J Hematol Oncol; 2016 Mar; 9():20. PubMed ID: 26957312
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Co-loaded paclitaxel/rapamycin liposomes: Development, characterization and in vitro and in vivo evaluation for breast cancer therapy.
    Eloy JO; Petrilli R; Topan JF; Antonio HMR; Barcellos JPA; Chesca DL; Serafini LN; Tiezzi DG; Lee RJ; Marchetti JM
    Colloids Surf B Biointerfaces; 2016 May; 141():74-82. PubMed ID: 26836480
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gadolinium-conjugated PLA-PEG nanoparticles as liver targeted molecular MRI contrast agent.
    Chen Z; Yu D; Liu C; Yang X; Zhang N; Ma C; Song J; Lu Z
    J Drug Target; 2011 Sep; 19(8):657-65. PubMed ID: 21091273
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Apolipoprotein E Peptide-Guided Disulfide-Cross-Linked Micelles for Targeted Delivery of Sorafenib to Hepatocellular Carcinoma.
    Li Y; Wei J; Wei Y; Cheng L; Guo B; Meng F; Li F; Zhong Z
    Biomacromolecules; 2020 Feb; 21(2):716-724. PubMed ID: 31809037
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Smart thermosensitive liposomes for effective solid tumor therapy and in vivo imaging.
    Affram K; Udofot O; Singh M; Krishnan S; Reams R; Rosenberg J; Agyare E
    PLoS One; 2017; 12(9):e0185116. PubMed ID: 28934281
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sorafenib and 2,3,5-triiodobenzoic acid-loaded imageable microspheres for transarterial embolization of a liver tumor.
    Choi JW; Park JH; Cho HR; Chung JW; Kim DD; Kim HC; Cho HJ
    Sci Rep; 2017 Apr; 7(1):554. PubMed ID: 28373713
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A multifunctional lipid that forms contrast-agent liposomes with dual-control release capabilities for precise MRI-guided drug delivery.
    Liu C; Ewert KK; Wang N; Li Y; Safinya CR; Qiao W
    Biomaterials; 2019 Nov; 221():119412. PubMed ID: 31419656
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sorafenib suppresses the epithelial-mesenchymal transition of hepatocellular carcinoma cells after insufficient radiofrequency ablation.
    Dong S; Kong J; Kong F; Kong J; Gao J; Ji L; Pan B; Chen L; Zheng L; Sun W
    BMC Cancer; 2015 Nov; 15():939. PubMed ID: 26620566
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhanced oral absorption of sorafenib via the layer-by-layer deposition of a pH-sensitive polymer and glycol chitosan on the liposome.
    Zhao M; Lee SH; Song JG; Kim HY; Han HK
    Int J Pharm; 2018 Jun; 544(1):14-20. PubMed ID: 29655795
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MRI monitoring of nanocarrier accumulation and release using Gadolinium-SPIO co-labelled thermosensitive liposomes.
    Lorenzato C; Oerlemans C; van Elk M; Geerts WJ; Denis de Senneville B; Moonen C; Bos C
    Contrast Media Mol Imaging; 2016 May; 11(3):184-94. PubMed ID: 26750715
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sorafenib enhances the chemotherapeutic efficacy of S-1 against hepatocellular carcinoma through downregulation of transcription factor E2F-1.
    Zhai JM; Yin XY; Lai YR; Hou X; Cai JP; Hao XY; Liang LJ; Zhang LJ
    Cancer Chemother Pharmacol; 2013 May; 71(5):1255-64. PubMed ID: 23435877
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MR characterization of mild hyperthermia-induced gadodiamide release from thermosensitive liposomes in solid tumors.
    Peller M; Schwerdt A; Hossann M; Reinl HM; Wang T; Sourbron S; Ogris M; Lindner LH
    Invest Radiol; 2008 Dec; 43(12):877-92. PubMed ID: 19002060
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combined delivery and magnetic resonance imaging of neural cell adhesion molecule-targeted doxorubicin-containing liposomes in experimentally induced Kaposi's sarcoma.
    Grange C; Geninatti-Crich S; Esposito G; Alberti D; Tei L; Bussolati B; Aime S; Camussi G
    Cancer Res; 2010 Mar; 70(6):2180-90. PubMed ID: 20215497
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Co-delivery of sorafenib and VEGF-siRNA via pH-sensitive liposomes for the synergistic treatment of hepatocellular carcinoma.
    Yao Y; Wang T; Liu Y; Zhang N
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1374-1383. PubMed ID: 30977418
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 2-Methoxyestradiol synergizes with sorafenib to suppress hepatocellular carcinoma by simultaneously dysregulating hypoxia-inducible factor-1 and -2.
    Ma L; Li G; Zhu H; Dong X; Zhao D; Jiang X; Li J; Qiao H; Ni S; Sun X
    Cancer Lett; 2014 Dec; 355(1):96-105. PubMed ID: 25218350
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MRI analysis of hydrogel-loaded apatinib for local therapy of hepatocellular carcinoma model in nude mice.
    Liu Z; Wang C; Wu G; Cheng J
    Biochem Biophys Res Commun; 2019 Feb; 509(2):529-534. PubMed ID: 30598262
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gadolinium-loaded calcium phosphate nanoparticles for magnetic resonance imaging of orthotopic hepatocarcinoma and primary hepatocellular carcinoma.
    Zhang NN; Lu CY; Shu GF; Li J; Chen MJ; Chen CM; Lv XL; Xu XL; Weng W; Weng QY; Tang BF; Du YZ; Ji JS
    Biomater Sci; 2020 Mar; 8(7):1961-1972. PubMed ID: 32064471
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Simultaneous inhibition of tumor growth and angiogenesis for resistant hepatocellular carcinoma by co-delivery of sorafenib and survivin small hairpin RNA.
    Shen J; Sun H; Meng Q; Yin Q; Zhang Z; Yu H; Li Y
    Mol Pharm; 2014 Oct; 11(10):3342-51. PubMed ID: 24495194
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.